Author:
Henes J. C.,Schulze-Koops H.,Witt M.,Tony H. P.,Mueller F.,Grunke M.,Czihal M.,Dörner T.,Proft F.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Ahmed MM, Mubashir E, Hayat S, Fowler M, Berney SM (2007) Treatment of refractory temporal arteritis with adalimumab. Clin Rheumatol 26:1353–1355
2. Bhatia A, Ell PJ, Edwards JC (2005) Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis. Ann Rheum Dis 64:1099–1100
3. Broder MS, Sarsour K, Chang E, Collinson N, Tuckwell K, Napalkov P, Klearman M (2016) Corticosteroid-related adverse events in patients with giant cell arteritis: a claims-based analysis. Semin Arthritis Rheum 46:246–252
4. Buttgereit F, Dejaco C, Matteson EL, Dasgupta B (2016) Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA 315:2442–2458
5. Caltran E, Di Colo G, Ghigliotti G, Capecchi R, Catarsi E, Puxeddu I, Migliorini P, Tavoni A (2014) Two takayasu arteritis patients successfully treated with rituximab. Clin Rheumatol 33:1183–1184
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献